Document Type
Article
Publication Date
6-15-2023
Abstract
Periprosthetic joint infection (PJI) is a rare yet devastating complication following total joint arthroplasty (TJA). Early and accurate diagnosis of PJI is paramount in order to maximize the chances of successful treatment. However, we are yet to identify a single “gold standard” test for the diagnosis of PJI. As a result, the diagnosis of PJI is often challenging. Currently, the 2018 ICM definition of PJI is the only validated diagnostic criteria available. This article will review the importance of serum and synovial biomarkers in the diagnosis of PJI. In addition, it will provide a brief overview of the emerging modalities for the identification of infections in this setting.
Recommended Citation
Yilmaz, Mehmet Kursat; Abbaszadeh, Ahmad; Tarabichi, Saad; Azboy, Ibrahim; and Parvizi, Javad, "Diagnosis of Periprosthetic Joint Infection: The Utility of Biomarkers in 2023" (2023). Rothman Institute Faculty Papers. Paper 221.
https://jdc.jefferson.edu/rothman_institute/221
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.
Language
English
Comments
This article is the author's final published version in Antibiotics, Volume 12, Issue 6, 2023, Article number 1054.
The published version is available at https://doi.org/10.3390/antibiotics12061054. Copyright © 2023 by the authors. Licensee MDPI, Basel, Switzerland.